The dual role of empagliflozin: Cardio renal protection in T2DM patients

Empagliflozin (Jardiance®) is an insulin independent antihyperglycemic agent used in treatment of T2D.The drug is a sodium glucose cotransporter-2 (SGLT2) inhibitor approved in USA and Europe and other countries of the world. As empagliflozin demonstrates cardioprotective and Reno protective propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiq, Aimen, Mahboob, Eman, Samad, Muhammad Ammar, Ur Rehman, Mohammad Hassam, Tharwani, Zoaib Habib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486862/
https://www.ncbi.nlm.nih.gov/pubmed/36147179
http://dx.doi.org/10.1016/j.amsu.2022.104555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486862/
https://www.ncbi.nlm.nih.gov/pubmed/36147179
http://dx.doi.org/10.1016/j.amsu.2022.104555

Ejemplares similares